Latest Breaking News On - Journey centers - Page 1 : vimarsana.com

Optimi Health, ATMA Sign Letter of Intent To Advance Phase II Clinical Trial Group and Individual Administration Protocol For Major Depressive Disorder

VANCOUVER, British Columbia, May 22, 2024 -- Optimi Health Corp. , a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing in controlled substances such as...

Optimi Health Advances Psychedelic Therapy Trials

Optimi Health (TSE:OPTI) has released an update. Optimi Health Corp. has partnered with ATMA Journey Centers to supply GMP psilocybin for Phase II ...

Optimi Health Completes First Production of Novel MDMA Drug Candidate OPTI-MHCL

The Company is producing OPTI-MHCL in-house under its Health Canada issued Dealers Licence using Optimi's scalable, proprietary production method.

Inside Health Canada's contradictory rollout of psilocybin exemptions

B.C.-based advocacy group argues the federal health organization is 'acting in bad faith'

Alberta Puts Patients First By Regulating Psychedelic Therapy: Optimi Health

Microsmallcap.com: Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer's Disease

FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, Oct. 5, 2022 /PRNewswire/ -- A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer's

Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer's Disease

/PRNewswire/ -- A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer's disease, announcing recently that it has gotten...

Psychedelics May Make People Less Afraid of Death

/PRNewswire/ -- According to a new survey by Johns Hopkins Medicine researchers, people's attitudes toward death change after a psychedelic drug experience and...

Microsmallcap.com: Psychedelics May Make People Less Afraid of Death

FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, Sept. 7, 2022 /PRNewswire/ -- According to a new survey by Johns Hopkins Medicine researchers, people's attitudes toward

Lawsuit filed by family of Alberta's first "magic mushroom" patient

The claim alleges AHS doctors failed to order testing which would have either prolonged or saved his life.